J. Esteban

M. Buti, T. Pumarola, C. Perales, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir

E. Domingo, C. Rice, C. Perales, 2016, PloS one.

High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods

E. Domingo, M. Buti, M. Álvarez-Tejado, 2014, Journal of Clinical Microbiology.

High-resolution Hepatitis C virus (HCV) subtyping, using NS5B deep sequencing and 3

E. Domingo, M. Buti, S. Sauleda, 2014 .

Long interval between HCV infection and development of hepatocellular carcinoma.

J. Esteban, R. Esteban, J. Guàrdia, 2008, Liver.

Ultra-Deep Pyrosequencing Detects Conserved Genomic Sites and Quantifies Linkage of Drug-Resistant Amino Acid Changes in the Hepatitis B Virus Genome

E. Domingo, M. Buti, J. Esteban, 2012, PloS one.

Interferon‐α in acute posttransfusion hepatitis C:. A randomized, controlled trial

J. Esteban, J. Genescà, R. Esteban, 1992 .

Clinical and serological outcome of acute delta infection.

M. Buti, J. Esteban, J. Genescà, 1987, Journal of hepatology.

Anti-HD IgM as a marker of chronic delta infection.

M. Buti, J. Esteban, R. Esteban, 1987, Journal of hepatology.

Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C Virus

E. Domingo, C. Rice, C. Perales, 2016, Antimicrobial Agents and Chemotherapy.

Removal from liver transplantation list of a hepatitis C virus‐HIV co‐infected patient after successful treatment with sofosbuvir and daclatasvir

M. Crespo, J. Esteban, R. Esteban, 2016, Transplant infectious disease : an official journal of the Transplantation Society.

Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study

P. Marcellin, O. Weiland, A. Alberti, 2002, Hepatology.

HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN

M. Buti, M. Houghton, Q. Choo, 1989, The Lancet.

High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.

J. Esteban, J. Genescà, R. Esteban, 1991, Annals of internal medicine.

Blood-Borne Non-A, Non-B Hepatitis: Hepatitis C

J. Esteban, J. Genescà, H. Alter, 1991, Seminars in liver disease.

Incidence and outcome of hepatitis C virus infection after liver transplantation

C. Margarit, J. Esteban, J. Quer, 1994, Transplant international : official journal of the European Society for Organ Transplantation.

Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment

E. Domingo, C. Rice, S. Manrubia, 2017, Journal of Virology.

The clinical picture of acute and chronic hepatitis C.

S. Sauleda, J. Córdoba, J. Esteban, 1994, Current studies in hematology and blood transfusion.

Immunohistochemistry of minor salivary gland biopsy specimens from patients with Sjögren’s syndrome with and without hepatitis C virus infection

J. Esteban, J. Coll, J. Guardia, 1997, Annals of the rheumatic diseases.

Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma

M. Klammer, J. Esteban, T. Tanwandee, 2022, World journal of gastroenterology.

Labeling may be an important cause of reduced quality of life in chronic hepatitis C.

J. Córdoba, J. Esteban, J. Reyes, 2003 .

Labeling May Be an Important Cause of Reduced Quality of Life in Chronic Hepatitis C

J. Córdoba, J. Esteban, J. Reyes, 2003, American Journal of Gastroenterology.

Improved Attachment of Natural HCV Isolate to Daudi Cells upon Elimination of Immune Complexes and Close pH Control

J. Esteban, J. Quer, R. Esteban, 2005, Intervirology.

HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).

A. Neumann, J. Pawlotsky, F. Negro, 2007, Gastroenterology.

Hepatitis C: molecular biology, pathogenesis, epidemiology, clinical features, and prevention.

J. Esteban, J. Genescà, H. Alter, 1992, Progress in liver diseases.

Profiles of GBV‐C/hepatitis G virus markers in patients coinfected with hepatitis C virus

S. Sauleda, J. Esteban, R. Esteban, 1999, Journal of medical virology.

Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus

E. Domingo, M. Buti, C. Perales, 2018, BMC Infectious Diseases.

Hepatotoxicity of antiretroviral drugs in HIV HCV patients with congenital coagulopathies followed at an Haemophilia Unit during a decade

C. Tural, S. Sauleda, J. Esteban, 2006 .

Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation

M. Martell, J. Esteban, J. Quer, 1994, Journal of virology.

WHEN SHOULD AT-RISK INFANTS BE BOOSTED WITH HEPATITIS B VACCINE?

J. Esteban, J. Genescà, R. Esteban, 1987, The Lancet.

Non-invasive prediction of liver related events in HCV compensated advanced chronic liver disease patients after oral antivirals.

M. Buti, X. Forns, J. Esteban, 2020, Journal of hepatology.

Hepatitis b virus replication in acute hepatitis B, acute hepatitis B virus‐hepatitis delta virus coinfection and acute hepatitis delta superinfection

M. Buti, J. Esteban, J. Genescà, 1987, Hepatology.

High frequency of antibodies to the hepatitis C virus among patients with hepatocellular carcinoma.

J. Esteban, L. Castells, V. Vargas, 1990, Annals of internal medicine.

Hepatitis C virus infection in renal transplant recipients: epidemiology, clinical impact, serological confirmation and viral replication.

S. Sauleda, J. Vila, J. Esteban, 1995, Journal of hepatology.

Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature

M. Manns, H. Thomas, S. Sauleda, 2000 .

Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research.

M. Manns, H. Thomas, S. Sauleda, 2000, European journal of gastroenterology & hepatology.

T cell responses and viral variability in blood donation candidates with occult hepatitis B infection.

S. Sauleda, J. Esteban, J. Quer, 2012, Journal of hepatology.

The frequency of defective genomes in Omicron differs from that of the Alpha, Beta and Delta variants

T. Pumarola, A. Antón, N. Saubí, 2022, Scientific Reports.

Quasispecies Fitness Partition to Characterize the Molecular Status of a Viral Population. Negative Effect of Early Ribavirin Discontinuation in a Chronically Infected HEV Patient

E. Domingo, M. Buti, A. Bosch, 2022, International journal of molecular sciences.

DITTO-HCV early viral kinetics report - novel decline patterns in gen 1 but not gen 2–3 patients treated with PEG-interferon-alfa-2a and ribavirin

A. Neumann, J. Pawlotsky, F. Negro, 2002 .

Clinical implications of positive tests for antibodies to human immunodeficiency virus type 1 in asymptomatic blood donors.

H. Klein, J. Esteban, E. Read, 1989, The New England journal of medicine.

Treatment with Interferon plus Ribavirin in anti-HIV Negative Patients with Congenital Coagulation Disorders and Chronic Hepatitis C

S. Sauleda, J. Esteban, R. Esteban, 2000, Thrombosis and Haemostasis.

Transmission of hepatitis C virus by a cardiac surgeon.

M. Martell, J. Esteban, J. Quer, 1996, The New England journal of medicine.

Sexual Transmission of Hepatitis C Virus From a Patient With Chronic Disease to His Sex Partner After Removal of an Intrauterine Device

M. Martell, J. Esteban, J. Quer, 2003, Sexually transmitted diseases.

Transmission of low‐density hepatitis C viral particles during sexually transmitted acute resolving infection

P. André, V. Lotteau, J. Esteban, 2008, Journal of medical virology.

Phylogenetic analysis of an epidemic outbreak of acute hepatitis C in HIV-infected patients by ultra-deep pyrosequencing.

X. Forns, F. González-Candelas, J. Mallolas, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C.

J. Caylà, J. Esteban, C. Solé, 2013, Journal of hepatology.

Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients

T. Pumarola, R. Ferrer, A. Antón, 2020, bioRxiv.

The changing epidemiology of hepatitis C virus infection in Europe.

S. Sauleda, J. Esteban, J. Quer, 2008, Journal of hepatology.

Reversal of nonstructural protein 3‐specific CD4+ T cell dysfunction in patients with persistent hepatitis C virus infection

S. Sauleda, J. Esteban, J. Quer, 2012, Journal of viral hepatitis.

Prevalence of hepatitis G virus in healthy children in liver disease, and human immunodeficiency virus-1 infection: response to interferon.

S. Sauleda, J. Esteban, R. Esteban, 2000, Journal of pediatric gastroenterology and nutrition.

The presence of anti‐hcv antibodies in the serum of patients with chronic active hepatitis and antinuclear antibodies

M. Buti, J. Rakela, A. Czaja, 1990, Hepatology.

The Impact of Rapid Evolution of the Hepatitis Viruses

M. Buti, A. Bosch, M. Martell, 2008 .

Chapter 13 – The Impact of Rapid Evolution of the Hepatitis Viruses

W. Carman, M. Martell, J. Esteban, 1999 .

Extinction of Hepatitis C Virus by Ribavirin in Hepatoma Cells Involves Lethal Mutagenesis

E. Domingo, A. M. Ortega-Prieto, C. Perales, 2013, PloS one.

Broad and Dynamic Diversification of Infectious Hepatitis C Virus in a Cell Culture Environment

E. Domingo, C. Perales, C. Briones, 2019, Journal of Virology.

The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer.

A. Valencia, E. Kieff, M. Fraga, 2008, Genome research.

New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents

M. Buti, J. Esteban, J. Quer, 2010, Infection and drug resistance.

Naturally occurring NS3-protease-inhibitor resistant mutant A156T in the liver of an untreated chronic hepatitis C patient.

S. Sauleda, J. Esteban, J. Quer, 2008, Virology.

The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment

M. Manns, M. Buti, N. Voirin, 2004, Journal of medical virology.

Prolonged inhibition of hepatitis B virus replication with vidarabine monophosphate in chronic active type B hepatitis.

M. Buti, J. Esteban, R. Esteban, 2008, Liver.

Peginterferon alpha‐2b plus ribavirin vs interferon alpha‐2b plus ribavirin for chronic hepatitis C in HIV‐coinfected patients

M. Buti, S. Sauleda, I. Ocaña, 2007, Journal of viral hepatitis.

International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C.

A. Neumann, J. Pawlotsky, F. Negro, 2005, Journal of hepatology.

Severe hepatic failure after ARA-A-prednisolone for chronic type B hepatitis.

M. Buti, J. Esteban, R. Esteban, 1987, Gastroenterology.

Evaluation of hepatitis C virus RNA RT/PCR qualitative and quantitative second generation assays.

S. Sauleda, M. Martell, J. Esteban, 2001, Journal of virological methods.

High-Throughput Real-Time Reverse Transcription-PCR Quantitation of Hepatitis C Virus RNA

S. Sauleda, J. Esteban, J. Quer, 1999, Journal of Clinical Microbiology.

Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.

J. Esteban, R. Esteban, António Gonzalez, 1990, The New England journal of medicine.

Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1

S. Sauleda, J. Esteban, R. Esteban, 2014, Journal of viral hepatitis.

Whole-genome characterization and resistance-associated substitutions in a new HCV genotype 1 subtype

M. Maciá, J. Esteban, J. Quer, 2019, Infection and drug resistance.

Resistance‐associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure

M. Buti, R. Macenlle, J. Esteban, 2021, Journal of viral hepatitis.

Recurrent hepatitis C virus infection after liver transplantation: immunohistochemical assessment of the viral antigen.

J. Esteban, R. Esteban, J. Guàrdia, 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Abacavir Coadministration Does Not Interfere with the Suppressive Activity of Ribavirin in An HCV Replicon System

A. Curran, E. Ribera, V. Falcó, 2011, Antiviral therapy.

Outcome of early vs. deferred antiviral treatment for recurrent hepatitis C in liver transplant recipients.

S. Sauleda, J. Esteban, R. Esteban, 2014, Annals of hepatology.

Twelve-Week Posttreatment Follow-Up to Predict Sustained Virologic Response for Recurrent Hepatitis C Infection in Liver Recipients

J. Esteban, R. Esteban, G. Sapisochin, 2012, Transplantation.

Utility of early testing for HCV viremia as predictive factor of sustained response during interferon or interferon plus ribavirin treatment.

S. Sauleda, J. Esteban, R. Esteban, 2000, Journal of hepatology.

Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus–infected patients with congenital coagulation disorders

S. Sauleda, J. Esteban, R. Esteban, 2001, Hepatology.

Hepatitis E virus infection in acute hepatitis in Spain.

M. Buti, J. Esteban, R. Esteban, 1995, Journal of virological methods.

A proposed system for the nomenclature of hepatitis C viral genotypes

E. Holmes, C. Rice, P. Simmonds, 1994, Hepatology.

Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV: a pilot trial.

A. Curran, E. Ribera, V. Falcó, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patients

M. Buti, S. Sauleda, E. Ribera, 2007, AIDS.

Structural analysis of hepatitis C RNA genome using DNA microarrays.

C. Briones, M. Martell, J. Esteban, 2004, Nucleic acids research.

Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality.

S. Mano, M. Yuen, M. Mizokami, 2006, Gastroenterology.

Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant

E. Domingo, M. Buti, C. Perales, 2018, Infection and drug resistance.

317 International multicenter, randomized, controlled study comparing standard versus dynamically individualized treatment in patients with chronic hepatitis C (DITTO-HCV) project)

J. Pawlotsky, S. Zeuzem, J. Esteban, 2003 .

Quasispecies dynamics in hepatitis C liver transplant recipients receiving grafts from hepatitis C virus infected donors.

E. Domingo, X. Forns, J. Esteban, 2015, The Journal of general virology.

Multicenter evaluation of the elecsys® anti‐HCV II assay for the diagnosis of hepatitis C virus infection

G. Pantaleo, J. Esteban, H. Schennach, 2013, Journal of medical virology.

Sofosbuvir and daclatasvir in mono- and HIV-coinfected patients with recurrent hepatitis C after liver transplant.

I. Bilbao, M. Crespo, J. Esteban, 2017, Annals of hepatology.

Immunoprophylaxis of perinatal transmission of the hepatitis B virus: Efficacy of hepatitis B immune globulin and hepatitis B vaccine in a low‐prevalence area

M. Buti, J. Esteban, J. Genescà, 1986, Journal of medical virology.

IMMUNOPROPHYLAXIS FOR INFANTS BORN TO HBsAg-POSITIVE MOTHERS

S. Shulman, J. Esteban, R. Esteban, 1983, The Lancet.

Chronic delta hepatitis: Detection of hepatitis delta virus antigen in serum by immunoblot and correlation with other markers of delta viral replication

M. Buti, J. Esteban, R. Esteban, 1989, Hepatology.

Hepatitis D virus RNA in acute delta infection: Serological profile and correlation with other markers of hepatitis D virus infection

M. Buti, J. Esteban, R. Esteban, 1988, Hepatology.

SEROLOGICAL MARKERS FOR DELTA HEPATITIS

M. Buti, J. Esteban, R. Esteban, 1987, The Lancet.

Hepatitis C virus (HCV)‐specific T‐cell responses among recombinant immunoblot assay‐3–indeterminate blood donors: a confirmatory evidence of HCV exposure

S. Sauleda, J. Esteban, J. Quer, 2009, Transfusion.

associated with human cancer The dynamic DNA methylomes of double-stranded DNA viruses Material Supplemental

A. Valencia, E. Kieff, M. Fraga, 2009 .

Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells

J. Prieto, J. Lasarte, J. Esteban, 2011, Hepatology.

Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.

J. Prieto, J. Lasarte, J. Esteban, 2007, Antiviral research.

Identification of hepatitis C virus genotype 3 by a commercial assay challenged by natural polymorphisms detected in Spain from patients with diverse origins.

J. Esteban, J. Quer, J. Gregori, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Nosocomial transmission of hepatitis C virus during contrast-enhanced computed tomography scanning

J. Vaqué, M. Martell, J. Esteban, 2008, European journal of gastroenterology & hepatology.

Evaluation of RNA and E2 antibodies in prospectively followed recipients of hepatitis G virus‐infected blood

S. Sauleda, J. Esteban, J. Quer, 1999, Transfusion.

Clinical Significance of Hepatitis C Virus Genotypes

G. Dusheiko, J. Esteban, J. Kolberg, 2000 .

IMPORTANCE OF WESTERN BLOT ANALYSIS IN PREDICTING INFECTIVITY OF ANTI-HTLV-III/LAV POSITIVE BLOOD

J. Esteban, H. Alter, A. Bodner, 1985, The Lancet.

Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study

P. Marcellin, O. Weiland, A. Alberti, 2002 .

Synergistic Lethal Mutagenesis of Hepatitis C Virus

E. Domingo, C. Perales, Elena Moreno, 2019, Antimicrobial Agents and Chemotherapy.

Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype

E. Domingo, C. Rice, C. Perales, 2013, Journal of Virology.

Deep sequencing in the management of hepatitis virus infections.

E. Domingo, A. Bosch, R. Pintó, 2017, Virus research.

Ultra-Deep Pyrosequencing (UDPS) Data Treatment to Study Amplicon HCV Minor Variants

Francisco Rodríguez-Frías, Josep Gregori, E. Domingo, 2013, PloS one.

New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors.

M. Buti, C. Perales, J. Esteban, 2018, The Journal of general virology.

Assessment of a Novel Automatic Real-Time PCR Assay on the Cobas 4800 Analyzer as a Screening Platform for Hepatitis C Virus Genotyping in Clinical Practice: Comparison with Massive Sequencing

M. Buti, T. Pumarola, J. Esteban, 2016, Journal of Clinical Microbiology.

Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from Argentina.

M. Buti, J. Esteban, J. Quer, 2013, World journal of gastroenterology.

Nucleotide and Amino Acid Complexity of Hepatitis C Virus Quasispecies in Serum and Liver

S. Sauleda, J. Esteban, R. Esteban, 2000, Journal of Virology.

Viral quasispecies complexity measures.

E. Domingo, C. Perales, J. Esteban, 2016, Virology.

Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus

E. Domingo, C. Rice, E. Martínez-Salas, 2014, Journal of Virology.

Prevalence of Hepatitis C Virus Infection, Genotypes and Subtypes in Migrants from Pakistan in Barcelona, Spain

J. Niubó, J. Esteban, J. Quer, 2022, Infection and drug resistance.

Response to Heish et al.

R. Simó, A. Lecube, C. Hernández, 2008, The American Journal of Gastroenterology.

Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen.

M. Crespo, J. Esteban, J. Pineda, 2008, The Journal of antimicrobial chemotherapy.

IL28B genetic variation and hepatitis C virus–specific CD4+ T‐cell responses in anti‐HCV‐positive blood donors

S. Sauleda, J. Esteban, J. Quer, 2012, Journal of viral hepatitis.

Epidemiological trends of HIV‐1 infection in blood donors from Catalonia, Spain (2005‐2014)

S. Sauleda, E. Ribera, J. Esteban, 2017, Transfusion.

Quality of life and cognitive function in hepatitis C at different stages of liver disease.

S. Sauleda, J. Esteban, R. Esteban, 2003, Journal of hepatology.

Structure of replicating hepatitis C virus (HCV) quasispecies in the liver may not be reflected by analysis of circulating HCV virions

M. Martell, J. Esteban, J. Genescà, 1997, Journal of virology.

Long‐term follow‐up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver‐related complications

H. Thomas, S. Sauleda, A. Alberti, 2007, Journal of viral hepatitis.

Hepatitis C viral quasispecies

M. Martell, J. Esteban, J. Quer, 1999, Journal of viral hepatitis.

Early detection of nonresponse to interferon plus ribavirin combination treatment of chronic hepatitis C

S. Sauleda, M. Martell, J. Esteban, 2002, Journal of viral hepatitis.

Rare haplotype load as marker for lethal mutagenesis

E. Domingo, C. Perales, J. Esteban, 2018, PloS one.

Resistance of high fitness hepatitis C virus to lethal mutagenesis.

E. Domingo, A. Gomez-Gonzalez, C. Perales, 2018, Virology.

Effect of Bottlenecking on Evolution of the Nonstructural Protein 3 Gene of Hepatitis C Virus during Sexually Transmitted Acute Resolving Infection

S. Sauleda, M. Martell, J. Esteban, 2005, Journal of Virology.

Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study

A. Neumann, J. Pawlotsky, F. Negro, 2012, BMC Gastroenterology.

Identification of host and viral factors involved in a dissimilar resolution of a hepatitis C virus infection

E. Domingo, S. Sauleda, C. Perales, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Longitudinal Evaluation of the Structure of Replicating and Circulating Hepatitis C Virus Quasispecies in Nonprogressive Chronic Hepatitis C Patients

J. Esteban, R. Esteban, Jordi Gómez, 2001, Journal of Virology.

Lack of HIV transmission after hepatitis B immunoprophylaxis

J. Esteban, J. Genescà, R. Esteban, 2005, Infection.

Deep-sequencing study of HCV G4a resistance-associated substitutions in Egyptian patients failing DAA treatment

J. Esteban, J. Quer, J. Gregori, 2019, Infection and drug resistance.

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

Dao Sen Wang, M. Poljak, F. Ceccherini‐Silberstein, 2022, JHEP reports : innovation in hepatology.

Predictive value of alt levels on histological findings in chronic hepatitis C: a European collaborative study

P. Marcellin, O. Weiland, A. Alberti, 2001 .

Glucose Abnormalities Are an Independent Risk Factor for Nonresponse to Antiviral Treatment in Chronic Hepatitis C

R. Simó, A. Lecube, C. Hernández, 2007, The American Journal of Gastroenterology.

Interferon-alpha in acute posttransfusion hepatitis C: a randomized, controlled trial.

J. Esteban, J. Genescà, R. Esteban, 1992, Hepatology.

Hepatitis B virus infection in Danish dentists. A case-control and follow-up study.

M. Melbye, F. Scheutz, P. Ebbesen, 1988, American Journal of Epidemiology.

Expression of Wilms' tumor suppressor in the liver with cirrhosis: Relation to hepatocyte nuclear factor 4 and hepatocellular function

J. Prieto, M. Ávila, J. Herrero, 2003, Hepatology.

Lack of association between hepatitis G virus and multiple sclerosis

X. Montalban, S. Sauleda, J. Río, 1998, Journal of neurology, neurosurgery, and psychiatry.

Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients

I. Bilbao, C. Perales, J. Esteban, 2021, Genes.

Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case‐Control Study

J. Esteban, T. Tanwandee, W. Sukeepaisarnjaroen, 2021, Hepatology communications.

A randomized controlled trial of α-interferon in acute postransfusion C hepatitis

I. Caragol, J. Esteban, J. Genescà, 1990 .

Early Monitoring of Ribavirin Serum Concentration is not Useful to Optimize Hepatitis C Virus treatment in HIV-Coinfected Patients

S. Sauleda, A. Curran, E. Ribera, 2007, Antiviral therapy.

Early Antiviral Treatment of Hepatitis C Virus Recurrence after Liver Transplantation in HIV-Infected Patients

S. Sauleda, I. Bilbao, C. Margarit, 2006, Antiviral therapy.

Prevalence of circulating antibodies against the hepatitis C virus among different risk groups in Spain

M. Buti, M. Houghton, J. Esteban, 1989 .

Specific Cleavage of Hepatitis C Virus RNA Genome by Human RNase P*

J. Lytle, M. Martell, J. Esteban, 2002, The Journal of Biological Chemistry.

A proposed system for the nomenclature of hepatitis C viral genotypes

E. Holmes, C. Rice, P. Simmonds, 1994, Hepatology.

Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion‐associated hepatitis: Final report of a prospective trial

J. Esteban, J. Quer, R. Esteban, 1995, Hepatology.

Host-dependent editing of SARS-CoV-2 in COVID-19 patients

J. Abril, T. Pumarola, A. Antón, 2021, Emerging microbes & infections.

Demonstration of specific detection of anti-HCV IgM core antibodies.

J. Esteban, F. Bonino, H. Hampl, 1996, Journal of virological methods.

Is it useful to perform the RNA test for hepatitis C in health care workers after an accidental needlestick?

J. Esteban, M. Bruguera, M. Campins, 2000, Journal of hepatology.

P14: HepatiC, the viral hepatitis C patients management application and database

M. Buti, X. Forns, J. Calleja, 2013 .

Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b.

J. Esteban, J. Quer, J. Genescà, 1993, Gut.

Humoral immune response to the E2 protein of hepatitis G virus is associated with long‐term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors

S. Sauleda, S. Schmolke, E. Tanaka, 1997, Hepatology.

New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents

M. Buti, J. Esteban, J. Quer, 2010 .

Infection and Drug Resistance Dovepress New Strategies for the Treatment of Hepatitis C Virus Infection and Implications of Resistance to New Direct-acting Antiviral Agents Jaume Guardia

M. Buti, J. Esteban, J. Quer, 2022 .

Comparison of Extracellular Vesicle Isolation Methods for miRNA Sequencing

E. Domingo, S. Sauleda, F. Borràs, 2023, International journal of molecular sciences.